Serum level of soluble Fas ligand are increased in advanced stage melanoma

被引:0
|
作者
Bullani, R
Viard, I
Saurat, JH
Ghanem, G
French, LE
机构
[1] Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland
[2] Univ Hosp Geneva, DHURDV, Geneva, Switzerland
[3] Inst Jules Bordet, B-1000 Brussels, Belgium
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
345
引用
收藏
页码:488 / 488
页数:1
相关论文
共 50 条
  • [41] Plasma soluble Fas and soluble Fas ligand in chronic glomerulonephritis
    Sano, H
    Asano, K
    Minatoguchi, S
    Hiraoka, J
    Fujisawa, K
    Nishigaki, K
    Yasuda, N
    Kumada, H
    Takemura, M
    Ohashi, H
    Seishima, M
    Fujiwara, T
    Fujiwara, H
    NEPHRON, 1998, 80 (02) : 153 - 161
  • [42] Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif
    Shiraishi, T
    Suzuyama, K
    Okamoto, H
    Mineta, T
    Tabuchi, K
    Nakayama, K
    Shimizu, Y
    Tohma, J
    Ogihara, T
    Naba, H
    Mochizuki, H
    Nagata, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (01) : 197 - 202
  • [43] High serum soluble Fas-ligand in cardiopulmonary arrest patients
    Iwama, H
    Tohma, J
    Nakamura, N
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2000, 18 (03): : 348 - 348
  • [44] Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure
    Perianayagam, MC
    Murray, SL
    Balakrishnan, VS
    Guo, DQ
    King, AJ
    Pereira, BJG
    Jaber, BL
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 136 (04): : 320 - 327
  • [45] Prognostic significance of serum soluble Fas ligand in patients with bladder cancer
    Mizutani, Y
    Hongo, F
    Nomoto, T
    Kawauchi, A
    Nakao, M
    Nakanishi, H
    Sato, N
    Miki, T
    JOURNAL OF UROLOGY, 2002, 167 (04): : 120 - 120
  • [46] Elevated serum-soluble fas ligand in Histiocytic necrotizing lymphadenitis
    Kei Kato
    Koichi Ohshima
    Keizo Anzai
    Junji Suzumiya
    Masahiro Kikuchia
    International Journal of Hematology, 2001, 73 : 84 - 86
  • [47] Elevated serum-soluble Fas ligand in histiocytic necrotizing lymphadenitis
    Kato, K
    Ohshima, K
    Anzai, K
    Suzumiya, J
    Kikuchi, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (01) : 84 - 86
  • [48] Serum soluble Fas level for detection and staging of prostate cancer
    Furuya, Y
    Fuse, H
    Masai, M
    ANTICANCER RESEARCH, 2001, 21 (05) : 3595 - 3598
  • [49] Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis
    Sugita, S
    Taguchi, C
    Takase, H
    Sagawa, K
    Sueda, J
    Fukushi, K
    Hikita, N
    Watanabe, T
    Itoh, K
    Mochizuki, M
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (10) : 1130 - 1134
  • [50] Soluble Fas Antigen and Soluble Fas Ligand in Intrauterine Growth Restriction
    Briana, Despina D.
    Baka, Stavroula
    Boutsikou, Maria
    Liosi, Sofia
    Vraila, Venetia-Maria
    Gourgiotis, Dimitrios
    Hassiakos, Dimitrios
    Malamitsi-Puchner, Ariadne
    NEONATOLOGY, 2010, 97 (01) : 31 - 35